PRACTICUM SUMMARY REPORT

Size: px
Start display at page:

Download "PRACTICUM SUMMARY REPORT"

Transcription

1 PRACTICUM SUMMARY REPORT Name: KOSSIVI AGBELENKO AFANVI, MD, CMgr, MCMI, PAHM Team Members: COMLAVI TSOMO ESSILIVI, RN, Lacs Health District Tuberculosis Focal Point; KOKOU MAWULE DAVI, MD, MPH, National Tuberculosis Program Coordinator Prof. YAWO DZAYISSE ATAKOUMA, Head of Pediatrics Department, UNIVERSITE DE LOME Project Title: Improving Lacs Health District Tuberculosis Program Performance University/Organization Name: UNIVERSITE DE LOME (TOGO) Health System Sponsor Name: Lacs Health District Aim of project (1-2 sentences) Our aim was to improve Lacs Health District Tuberculosis Program performance by improving the public health system related to TB patients treatment. Specifically, we wanted at least 85% treatment success rate of pulmonary TB patients in Lacs Health District by February 28th, Planned changes tested (2-3 sentences) Before the project, a systems and dialogic analysis of the public health system related to TB patients treatment revealed that it was not well-performing (weak coverage and quality of TB services, weak-functioning TB health information system, weak-performing health workforce, weak availability of HIV tests and antiretroviral for TB patients and low degree of patients participation in their care). For this project, the system was redesigned to correct the identified weaknesses. We will monitor the effectiveness of these changes using PDSA cycles. Predictions (2-3 sentences) By successfully implementing this project, we expect to have a more sustained public health system which definitely can achieve its goal: save lives. We will use a systems and dialogic approach to redesign and pilot the public health system. This novel approach is expected to better empower TB stakeholders to deal with their health condition. Results Present your results with a graph(s).

2

3 Summary of results (3-4 sentences): By combining our approach which we called the empowered DOTS (edots) to systematically putting TB-HIV coinfected patients under ART and asking for bacteriological culture and PCR in presence of cough after two months of a well observed treatment, we improved our TB program performance. We increased TB patient success rate from 80 percent to 95 percent between February 2012 and July 2013 in Lacs Health District in Togo. The lethality rate dropped from 13 percent to 5 percent, the failure to follow-up rate dropped from 3 percent to zero percent and the proportion of TB-HIV co-infected patients under ART increased from 24 to 100 percent. Learning (4-5 sentences) Comparison of questions, predictions, and analysis of data:

4 In our first PDSA, we were looking for which combinations of changes could help achieve at least 85 percent of treatment success rate. We predicted to achieve at least 85 percent of TB patients treatment success rate, 5 percent or less lethality rate among TB smear positive patient and 4 percent or less failure to follow-up rate among TB patients every month. The average treatment success rate moved from 80 percent to 90 percent between February and September 2012, the average lethality rate dropped from 13 percent to 5 percent (the prediction level) and the average failure to follow-up rate dropped to 2 percent. From April 2012, no failure to follow-up was noticed among TB patients for six consecutive months. We noticed that globally, we surpassed our predictions but also realized that the system could not sustain without decreasing TB-HIV co-infection lethality. In PDSA cycle # 2, we tried to know if systematically putting TB-HIV co-infected patients under antiretroviral treatment could help increase more TB patients' treatment success rate. We predicted to achieve at least 95 per cent the TB patients' treatment success rate by increasing the proportion of TB-HIV co-infected patients under antiretroviral treatment (ART). The average treatment success rate increased again from 90 percent to 94 percent. The prediction was not met due to treatment failure as a result of drug resistance. The proportion of TB-HIV co-infected patients under ART increased from 53 to 75 percent. Based on the knowledge that in presence of cough after two months of a well observed treatment, treatment failure can be suspected and a PCR and bacteriological culture could be asked for, we ran a third PDSA cycle after which we achieved on average 95 percent treatment success rate, zero percent treatment failure and 100 percent proportion of TB-HIV co-infected patients under ART. Impact on systems (3-4 sentences) Discuss the project s significance on the local system and any findings that may be generalizable to other systems: By raising TB patients treatment success rate, we allow hope to eliminating TB in Lacs Health District in the future. Successful treatment of individual cases reduces TB morbidity and mortality; reduces the number and period of infectious cases; and prevent the emergence of resistant strains. Other districts could use our tested approach, called the empowered DOTS (edots), and combine it to systematically putting TB-HIV co-infected patients under ART and asking for bacteriological culture and PCR in presence of cough after two months of a well observed treatment to improve their TB program performance. Conclusions (3-5 sentences) Summarize the outcome of the project. Is this project sustainable? What are the requirements for sustainability? Health systems performance at District level depends on factors such as the closeness of services to population; skilled workforce; ability to collect and analyze data and use information for action; population empowerment and good management and improvement capabilities of management team especially the Public Health Director. High TB patients success rate depends also on the availability of antiretroviral drugs. We strongly recommend every District Health Management Team member to increase his knowledge in improvement capabilities. Reflections/Discussions (5-7 sentences) Discuss the factors that promoted the success of the project and that were barriers to success. What did you learn from doing this project? What are your reflections on the role of the team? The success of the project was based on the systems analysis of the existing health system and the management and improvement capabilities of management team especially the Public Health Director. Improvement capabilities helped to understand variation and team management or (better) stakeholders management strengthens achievements from each step. Undoubtedly medical management requires strong clinical management competencies particularly clinical status monitoring during care to depict early signs of treatment failure to be managed. Population empowerment should be the future focus of health system to achieve high and sustainable performance. Health system should be managed as a system, taking into account all the six building blocks.

5 By signing this document (electronic signature is acceptable), I attest that the information provided by the learners in this project is accurate. LEARNER(S): Dr. KOSSIVI AGBELENKO AFANVI PUBLIC HEALTH MANAGEMENT FACULTY SPONSOR: HEALTH SYSTEM SPONSOR (if different from faculty sponsor): Prof. YAWO DZAYISSE ATAKOUMA Institution: Pediatrics Department, UNIVERSITE DE LOME Institution: AUTHORIZATION Do the learners, faculty sponsor, and health system sponsor authorize this project for publication at X Yes No

ANNEXURE A: EXPLANATORY NOTES ON THE DMR 164 REPORTING ON HIV AND TB FORM

ANNEXURE A: EXPLANATORY NOTES ON THE DMR 164 REPORTING ON HIV AND TB FORM ANNEXURE A: EXPLANATORY NOTES ON THE DMR 164 REPORTING ON HIV AND TB FORM The form and content of the explanatory note is to: Inform those responsible for completing the DMR 164 Reporting Form - as to

More information

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 1 Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 Daniel P. Dohony, MPH Division of Tuberculosis Elimination Centers for Disease Control and Prevention and Philadelphia TB Control

More information

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative

More information

Same-day diagnosis of tuberculosis by microscopy. Policy statement

Same-day diagnosis of tuberculosis by microscopy. Policy statement Same-day diagnosis of tuberculosis by microscopy Policy statement March 2010 Contents Abbreviations Executive summary 1. Background 2. Evidence for policy formulation 2.1 Synthesis of evidence 2.2 Management

More information

7.5 South-East Asian Region: summary of planned activities, impact and costs

7.5 South-East Asian Region: summary of planned activities, impact and costs PART II: GLOBAL AND REGIONAL SCENARIOS FOR TB CONTROL 26 215 7.5 South-East Asian Region: summary of planned activities, impact and costs Achievements DOTS expanded rapidly in the South-East Asian Region

More information

SUMMARY OF INTERIM REPORT

SUMMARY OF INTERIM REPORT EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL EXECUTIVE AGENCY FOR HEALTH AND CONSUMERS Health unit SUMMARY OF INTERIM REPORT Title: Empowering Civil Society and Public Health System to

More information

Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs

Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs What causes TB? TB is caused by the bacterium Mycobacterium tuberculosis. Although it can cause disease in

More information

11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction

11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction SECOND EDITION 2009 Madhukar Pai McGill University Introduction 1 Purpose of ISTC ISTC Version 2: Key Points 21 Standards Differ from existing guidelines: standards present what should be done, whereas,

More information

Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite

Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Riga East Clinical hospital, Centre for tuberculosis and lung diseases. Head of outpatient department.

More information

Successes and remaining barriers to routine TB screening and implementation of IPT in Cambodia

Successes and remaining barriers to routine TB screening and implementation of IPT in Cambodia Successes and remaining barriers to routine TB screening and implementation of IPT in Cambodia Mean Chhi Vun, MD, MPH NCHADS Director mchhivun@nchads.org Scaling up the implementation of the TB/HIV collaborative

More information

New Tuberculosis Guidelines. Jason Stout, MD, MHS

New Tuberculosis Guidelines. Jason Stout, MD, MHS New Tuberculosis Guidelines Jason Stout, MD, MHS Two New Sets of Guidelines Treatment of Drug-Susceptible Tuberculosis Clinical Infectious Diseases 2016; 63(7): e147-e195 Diagnosis of Tuberculosis in Adults

More information

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director. 30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE

More information

World Health Organization HIV/TB Facts 2011

World Health Organization HIV/TB Facts 2011 World Health Organization HIV/TB Facts 20 Note: The facts and figures of the HIV/TB Facts 20 are drawn from WHO HIV and TB surveillance data from 200 and 2009, as referenced below. Why is tuberculosis

More information

HIV and TB: What s the Latest and Greatest?

HIV and TB: What s the Latest and Greatest? HIV and TB: What s the Latest and Greatest? State-of-the-Art Technical Overview Project Concern International Mexico Lessons from a National Experience TB in Mexico 2008 18,172 new cases (TB all forms)

More information

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME MINISTRY OF HEALTH UGANDA TIOL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME Revised Strategic Plan 2015/16-2019/20 Monitoring and Evaluation Plan Narrative of the Operational, Budget and Technical Assistance

More information

Title: Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study

Title: Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study Author's response to reviews Title: Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study Authors: Delia Goletti (d.goletti@tiscali.it)

More information

The WHO END-TB Strategy

The WHO END-TB Strategy ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who

More information

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms) IMPACT INDICATORS (INDICATORS PER GOAL) HIV/AIDS TUBERCULOSIS MALARIA Reduced HIV prevalence among sexually active population Reduced HIV prevalence in specific groups (sex workers, clients of sex workers,

More information

TB/HIV Collaborative activities in Rwanda: From Policy to implementation.

TB/HIV Collaborative activities in Rwanda: From Policy to implementation. TB/HIV Collaborative activities in Rwanda: From Policy to implementation. Michel GASANA MD,MPH Head of TB and Other Respiratory Diseases Division. Rwanda / Ministry of Health RWANDA Superficie: 26,338

More information

10/2016. Children affected by HIV

10/2016. Children affected by HIV 10/2016 Children affected by HIV Introduction Welcome Anne Dankert Twitter: @AnneDankert1 Aids Fonds/STOP AIDS NOW! Ambition: to end AIDS by 2030 3 regions where we work: Sub Sahara Africa Asia Eastern

More information

Zero HIV infections Zero HIV deaths Zero HIV stigma. Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium

Zero HIV infections Zero HIV deaths Zero HIV stigma. Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium Zero HIV infections Zero HIV deaths Zero HIV stigma Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium Number of New HIV Diagnoses Overall decline in new HIV diagnoses and death in San

More information

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 TB Along the US/Mexico Border El Paso, Texas August 22-23, 2007 International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 Barbara J Seaworth MD Medical Director Heartland National

More information

POLICY FOR THE PREVENTION AND CONTROL OF TUBERCULOSIS

POLICY FOR THE PREVENTION AND CONTROL OF TUBERCULOSIS POLICY FOR THE PREVENTION AND CONTROL OF TUBERCULOSIS Policy No: 7.20 Approval Date: Review Date: Lead Director: Under Review Under Review Under Review Page 1 of 7 Polic y_for_the_prevention_and_control_of_tuberculosis

More information

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition

More information

Okinawa, Toyako, and Beyond: Progress on Health and Development

Okinawa, Toyako, and Beyond: Progress on Health and Development Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,

More information

Northwestern Polytechnic University

Northwestern Polytechnic University Clinical Tuberculosis Assessment by Health Care Provider Clinicians should review and verify the information in the Tuberculosis (TB) Screening Questionnaire (attached). Persons answering YES to any questions

More information

ACHAP LESSONS LEARNED IN BOTSWANA KEY INITIATIVES

ACHAP LESSONS LEARNED IN BOTSWANA KEY INITIATIVES ACHAP Together with our company s foundation, a U.S.-based, private foundation, and the Bill & Melinda Gates Foundation, we established the African Comprehensive HIV/AIDS Partnerships (ACHAP) in 2000 to

More information

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each

More information

TB Infection Control Policy. Scaling-up the implementation of collaborative TB/HIV activities in the Region of the

TB Infection Control Policy. Scaling-up the implementation of collaborative TB/HIV activities in the Region of the TB Infection Control Policy Scaling-up the implementation of collaborative TB/HIV activities in the Region of the Infection Control is aimed at minimizing the risk of TB transmission within populations

More information

Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work

Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection Results of Group Work DOTS expansion and enhancement Objective This group deals with the majority

More information

SAME-DAY-DIAGNOSIS OF TUBERCULOSIS BY MICROSCOPY - POLICY STATEMENT -

SAME-DAY-DIAGNOSIS OF TUBERCULOSIS BY MICROSCOPY - POLICY STATEMENT - SAME-DAY-DIAGNOSIS OF TUBERCULOSIS BY MICROSCOPY - POLICY STATEMENT - March 2010 EXECUTIVE SUMMARY Direct sputum smear microscopy is the most widely used test for the diagnosis of pulmonary tuberculosis

More information

COMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE

COMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE COMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE Exposing a hidden epidemic Kenya TB/HIV TEAM Introduction Population: 40 million 15 th among the 22 high TB burden countries 2012: TB case notification

More information

Managing Complex TB Cases Diana M. Nilsen, MD, RN

Managing Complex TB Cases Diana M. Nilsen, MD, RN Managing Complex TB Cases Diana M. Nilsen, MD, RN Director of Medical Affairs NYC Department of Health & Mental Hygiene Bureau of TB Control Case #1 You are managing a patient who was seen at a private

More information

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE)

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE) TB IN EMERGENCIES Department of Epidemic and Pandemic Alert and Response (EPR) Health Security and Environment Cluster (HSE) (Acknowledgements WHO Stop TB Programme WHO/STB) 1 Why TB? >33% of the global

More information

End of Programme Evaluation Report PLHIV Stand Up for Your Rights! Programme, Trócaire Zimbabwe

End of Programme Evaluation Report PLHIV Stand Up for Your Rights! Programme, Trócaire Zimbabwe End of Programme Evaluation Report PLHIV Stand Up for Your Rights! Programme, Trócaire Zimbabwe Summary of End of Programme Evaluation (December 2013) 1. Background The HIV Programme was a three year programme

More information

Doctors with Africa CUAMM

Doctors with Africa CUAMM Doctors with Africa CUAMM Founded in 1950 by prof. Canova Doctors with Africa CUAMM was the first NGO operating in the health field recognized by Italy 1300 people sent in Africa throughout the years 4330

More information

Tuberculosis the Silent Epidemic in Uganda s Greater Northern Region

Tuberculosis the Silent Epidemic in Uganda s Greater Northern Region a not-for-profit company Briefing on Research Findings TB 01 June 2018 Tuberculosis the Silent Epidemic in Uganda s Greater Northern Region By Norah Owaraga I have Tuberculosis (TB)? For me I had TB and

More information

TB Program Management San Antonio, Texas November 5-7, 2008

TB Program Management San Antonio, Texas November 5-7, 2008 TB Program Management San Antonio, Texas November 5-7, 2008 Infection Control Lynelle Phillips, RN, MPH November 7, 2008 Infection Control Lynelle Phillips, RN MPH Nurse Consultant Heartland National TB

More information

TB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014

TB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014 Sharing the Care: Working Together to Meet the Challenge of TB Presented by: Barbara Cole, RN, PHN, MSN Director, Disease Control County of Riverside Department of Public Health Curry International TB

More information

MEMORANDUM. Re: Guidance for follow-up of newly-arrived individual with Class B1 Tuberculosis Pulmonary Tuberculosis, no treatment

MEMORANDUM. Re: Guidance for follow-up of newly-arrived individual with Class B1 Tuberculosis Pulmonary Tuberculosis, no treatment MEMORANDUM To: From: Local Board of Health John Bernardo, MD, Tuberculosis Medical Officer Jennifer Cochran, MPH, Division Director Division of Global Populations and Infectious Disease Prevention Bureau

More information

South African goals and national policy

South African goals and national policy Connecting the dots for EMTCT A Decade of PMTCT South Africa has been one of the counties in sub-saharan Africa to be hard hit by the HIV virus. Despite this, the country did not implement its PMTCT programme

More information

Step 1. CDC Framework for Program Evaluation. Stakeholders Maryland Evaluation Team. Identify Stakeholders

Step 1. CDC Framework for Program Evaluation. Stakeholders Maryland Evaluation Team. Identify Stakeholders Maryland TB Program Evaluation Sputum Culture Conversion TB Program Managers Workshop February 22, 2011 CDC Framework for Program Evaluation Maryland Evaluation Team Cathy Goldsborough, RN, Former Nurse

More information

Nucleic Acid Amplification Test for Tuberculosis. Heidi Behm, RN, MPH Acting TB Controller HIV/STD/TB Program Oregon, Department of Health Services

Nucleic Acid Amplification Test for Tuberculosis. Heidi Behm, RN, MPH Acting TB Controller HIV/STD/TB Program Oregon, Department of Health Services Nucleic Acid Amplification Test for Tuberculosis Heidi Behm, RN, MPH Acting TB Controller HIV/STD/TB Program Oregon, Department of Health Services What is this test? Nucleic Acid Amplification Test (NAAT)

More information

VERSION STUDENT. Outbreak of Tuberculosis in a Homeless Men s Shelter. Cases in Population-Oriented Prevention (C-POP)-based teaching cases

VERSION STUDENT. Outbreak of Tuberculosis in a Homeless Men s Shelter. Cases in Population-Oriented Prevention (C-POP)-based teaching cases STUDENT VERSION This project has the objective to develop preventive medicine teaching cases that will motivate medical students, residents and faculty to improve clinical preventive competencies complemented

More information

Tuberculosis and HIV coinfection still a challenge in Central and Eastern Europe

Tuberculosis and HIV coinfection still a challenge in Central and Eastern Europe Tuberculosis and HIV coinfection still a challenge in Central and Eastern Europe Prof. A. Panteleev Pavlov First Saint Petersburg State Medical University 2 nd TB hospital, St. Petersburg 250 200 150

More information

DIFFERENT CAUSES OF ILLNESS AMONG ADULTS AND CHILDREN HAVING FEVER ATTENDING HEALTH CARE SERVICES IN MADAGASCAR

DIFFERENT CAUSES OF ILLNESS AMONG ADULTS AND CHILDREN HAVING FEVER ATTENDING HEALTH CARE SERVICES IN MADAGASCAR MEDICAL SCHOOL OF ANTANANARIVO UNIVERSITY DIFFERENT CAUSES OF ILLNESS AMONG ADULTS AND CHILDREN HAVING FEVER ATTENDING HEALTH CARE SERVICES IN MADAGASCAR Prof Randria Mamy Infectious diseases specialist

More information

ANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for tuberculosis programme managers

ANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for tuberculosis programme managers ANALYSIS AND USE OF HEALTH FACILITY DATA Guidance for tuberculosis programme managers WORKING DOCUMENT SEPTEMBER 2018 World Health Organization 2018 All rights reserved. This is a working document and

More information

Using Xpert to discontinue airborne isolation The Consensus Statement

Using Xpert to discontinue airborne isolation The Consensus Statement Using Xpert to discontinue airborne isolation The Consensus Statement Neha Shah, MD MPH Tuberculosis Control California Department of Public Health Centers for Disease Control and Prevention NAR February

More information

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 5/6/2011 Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Epidemiology of Substance Abuse and Tuberculosis: Where is the Problem? Debra Stephens, RN, BSN, MPH April 27, 2011 Debra Stephens,

More information

TB Contact Investigation

TB Contact Investigation Ann Raftery, RN, PHN, MS Curry International TB Center Overview Contact investigation as a core TB control and elimination activity Components of TB Contact Investigation TB Control Priority Strategies.

More information

Institut Pasteur du Cambodge scientific report and 2018 prospects Rapport 2017 et programmation scientifique 2018 IMMUNOLOGY PLATFORM

Institut Pasteur du Cambodge scientific report and 2018 prospects Rapport 2017 et programmation scientifique 2018 IMMUNOLOGY PLATFORM Institut Pasteur du Cambodge 2017 scientific report and 2018 prospects Rapport 2017 et programmation scientifique 2018 IMMUNOLOGY PLATFORM 3.4. IMMUNOLOGY PF (total 4 pages) 3.4.1. FUNCTIONAL STRUCTURE

More information

Contact Investigation

Contact Investigation Tuberculosis Ann Raftery, RN, PHN, MSc GHS Learning Objectives Upon completion of this session, participants will be able to: Describe the criteria used and method for determining the infectious period

More information

Application of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes

Application of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes Application of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes Dr Amal Bassili Stop TB unit, WHO, Regional Office for the Eastern Mediterranean Surveillance

More information

IHI South Africa Quarterly Report

IHI South Africa Quarterly Report IHI South Africa Quarterly Report September1 st November 31 st 2010 Executive Summary The Institute for Healthcare Improvement s South African country programme was started in 2005. Over the past five

More information

Yakima Health District BULLETIN

Yakima Health District BULLETIN Yakima Health District BULLETIN Summary Volume 13, Issue 1 February, 2014 Tuberculosis in Yakima County The rate of active tuberculosis (TB) in Yakima County has declined by about two-thirds over the past

More information

Post-2015 TB Elimination Strategy and Targets

Post-2015 TB Elimination Strategy and Targets Photo: Riccardo Venturi Vision and proposed framework for a Post-2015 TB Elimination Strategy and Targets Consultation on Eliminating the catastrophic economic burden of TB" Universal Health Coverage and

More information

1 Voluntary Counseling and Testing (for HIV) 2 Anti-retroviral Treatment

1 Voluntary Counseling and Testing (for HIV) 2 Anti-retroviral Treatment Summary 1. Outline of the Project Country: Republic of Zambia Project Title: HIV/AIDS and Tuberculosis Control Project Issue/Sector: Healthcare/population, infectious disease control Cooperation Scheme:

More information

Spectrum. Quick Start Tutorial

Spectrum. Quick Start Tutorial Spectrum Quick Start Tutorial March 2005 Table of Contents Introduction... 2 What you will learn... 4 Basic Steps in Using Spectrum... 4 Step 1. Installing Spectrum... 4 Step 2. Changing the language in

More information

Performance of RNTCP NTI Bulletin 2005,41/3&4,

Performance of RNTCP NTI Bulletin 2005,41/3&4, Performance of RNTCP NTI Bulletin 2005,41/3&4, 118-122 A Cohort Analysis of Performance of RNTCP in MS Subramanya Rao*, KP Unnikrishnan**, MA Sharada BACKGROUND Tuberculosis (TB) is one of the most serious

More information

Ram Sharan Gopali (MPH) Executive Director

Ram Sharan Gopali (MPH) Executive Director Ram Sharan Gopali (MPH) Executive Director Basic Facts of Nepal Nepal is a landlocked country located in the WHO Asian region at the edge of the Himalaya between India and the Peoples Republic of China

More information

The Lancet Infectious Diseases

The Lancet Infectious Diseases Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study Susan E Dorman, Samuel G Schumacher, David Alland et al. 2017

More information

Quality Improvement Methodology, Workflow Redesign and Outcomes Management

Quality Improvement Methodology, Workflow Redesign and Outcomes Management Quality Improvement Methodology, Workflow Redesign and Outcomes Management Jeffrey Hummel, MD, MPH Medical Director for Clinical Informatics, Qualis Health and UW Medicine Neighborhood Clinics July 28,

More information

IPT IMPLEMENTATION- SWAZILAND EXPERIENCE

IPT IMPLEMENTATION- SWAZILAND EXPERIENCE IPT IMPLEMENTATION- SWAZILAND EXPERIENCE Gugu Mchunu-National TB/HIV coordinator Programmatic Management of Latent TB infection consultation meeting Seoul, Republic of Korea,27-28 APRIL,2016 TB Epidemiology

More information

The Economic Cost of Non-adherence to TB Medicines Resulting from Stock-outs and Loss to Follow-up in Kenya

The Economic Cost of Non-adherence to TB Medicines Resulting from Stock-outs and Loss to Follow-up in Kenya The Economic Cost of Non-adherence to TB Medicines Resulting from Stock-outs and Loss to Follow-up in Kenya March 2017 Photo Credit: Francis Nsanga UHMG, Photoshare, Kenya RESEARCH SUMMARY A key element

More information

WHERE DO WE GO FROM HERE?

WHERE DO WE GO FROM HERE? WHERE DO WE GO FROM HERE? WHAT WILL BE REQUIRED TO ACHIEVE ZERO DEATHS FROM TUBERCULOSIS? SALMAAN KESHAVJEE, MD, PHD, SCM HARVARD MEDICAL SCHOOL BRIGHAM AND WOMEN S HOSPITAL PARTNERS IN HEALTH INTERNATIONAL

More information

2007 ACIP Recommendations for Influenza Vaccine. Anthony Fiore, MD, MPH Influenza Division, NCIRD, CDC

2007 ACIP Recommendations for Influenza Vaccine. Anthony Fiore, MD, MPH Influenza Division, NCIRD, CDC 2007 ACIP Recommendations for Influenza Vaccine Anthony Fiore, MD, MPH Influenza Division, NCIRD, CDC National Influenza Vaccine Summit April 19, 2007 Recommendation Changes for Influenza Vaccination:

More information

Opt-Out HIV Testing in U.S. Tuberculosis Clinics: A Survey of Current Practice and Perceived Barriers

Opt-Out HIV Testing in U.S. Tuberculosis Clinics: A Survey of Current Practice and Perceived Barriers Opt-Out HIV Testing in U.S. Tuberculosis Clinics: A Survey of Current Practice and Perceived Barriers Adrian Gardner MD, MPH Assistant Professor of Clinical Medicine, Infectious Diseases, Indiana University

More information

The Global Fund & UNICEF Partnership

The Global Fund & UNICEF Partnership The Global Fund & UNICEF Partnership Prof Michel D. Kazatchkine Executive Director UNICEF Executive Board February 9 th, 2011 The Global Fund Millennium Development Goals 1. Eradicate extreme poverty and

More information

Improving Asthma and. Management with Spirometry 360

Improving Asthma and. Management with Spirometry 360 Improving Asthma and COPD Diagnosis and Management with Spirometry 360 CIN Webinar March 28, 2012 1 University of Washington Spirometry 360 Team Jim Stout, MD, MPH Principal Investigator t Dennis Burges

More information

Session-1: Template for country presentation (EXISTING Indicators)

Session-1: Template for country presentation (EXISTING Indicators) Session-1: Template for country presentation (EXISTING Indicators) Instruction This presentation is expected to provide Country perspective on use of following Existing indicators among the top 10 indicators

More information

Tuberculosis Screening and IPT: Experience from India

Tuberculosis Screening and IPT: Experience from India Tuberculosis Screening and IPT: Experience from India Dr B.B.Rewari WHO National consultant Care, Support and Treatment National Programme Officer (ART) National AIDS Control Organization New Delhi-110001,

More information

COMMUNITY PARTNERS MEETING

COMMUNITY PARTNERS MEETING PUBLIC HEALTH & SYSTEMS IN ACTION COMMUNITY PARTNERS MEETING Presenter: Amy Fagan, Assistant Director of Health Date: February 23, 2017 HEALTH DISTRICT VISION HEALTHY PEOPLE, HEALTHY COMMUNITY HEALTH COALITION

More information

HIV-HBV coinfection in HIV population horizontally infected in early childhood between

HIV-HBV coinfection in HIV population horizontally infected in early childhood between UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE HIV-HBV coinfection in HIV population horizontally infected in early childhood between 1987-1990 Supervising professor: Prof. Cupşa Augustin

More information

EXPRESSION OF INTEREST New Horizons Advancing Pediatric HIV Care Donation Program

EXPRESSION OF INTEREST New Horizons Advancing Pediatric HIV Care Donation Program EXPRESSION OF INTEREST New Horizons Advancing Pediatric HIV Care Donation Program Background With the release of the 2014 UNAIDS 90-90- 90 treatment target, programs are expected to scale- up efforts to

More information

IHI South Africa Quarterly Report

IHI South Africa Quarterly Report IHI South Africa Quarterly Report April 1 st -July 31 st 2010 Executive Summary The South African country programme was started by the Institute for Healthcare Improvement in 2005. Over the past five years,

More information

Errors in Dx and Rx of TB

Errors in Dx and Rx of TB Errors in Dx and Rx of TB David Schlossberg, MD, FACP Professor of Medicine Temple University School of Medicine Medical Director, TB Control Program Philadelphia Department of Public Health TB Still a

More information

International Training Course on Comprehensive Care Management for Children and Adolescents living with HIV/AIDS

International Training Course on Comprehensive Care Management for Children and Adolescents living with HIV/AIDS Thailand s Annual International Training Course (AITC) Course Information International Training Course on Comprehensive Care Management for Children and Adolescents living with HIV/AIDS 11 22 March 2019

More information

Improved diagnosis of extrapulmonary tuberculosis by antigen detection using immunochemistry-based assay. Tehmina Mustafa

Improved diagnosis of extrapulmonary tuberculosis by antigen detection using immunochemistry-based assay. Tehmina Mustafa Improved diagnosis of extrapulmonary tuberculosis by antigen detection using immunochemistry-based assay Tehmina Mustafa Overview Introduction: extrapulmonary tuberculosis (TB) & diagnostic challenges

More information

Diagnosis and Medical Management of Latent TB Infection

Diagnosis and Medical Management of Latent TB Infection Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,

More information

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director Tuberculosis What you need to know James Zoretic M.D., M.P.H. Regions 2 and 3 Director What is Tuberculosis? Tuberculosis, (TB) is a communicable disease caused by the Mycobacterium tuberculosis bacillus

More information

Latent tuberculosis infection

Latent tuberculosis infection Latent tuberculosis infection Updated and consolidated guidelines for programmatic management ANNEX 2 Evidence-to-Decision and GRADE tables Latent tuberculosis infection Updated and consolidated guidelines

More information

TB Situation in Zambia/ TB Infection Control Program. Dr N Kapata Zambia National TB/Leprosy Control Programme Manager

TB Situation in Zambia/ TB Infection Control Program. Dr N Kapata Zambia National TB/Leprosy Control Programme Manager / TB Infection Control Program Dr N Kapata Zambia National TB/Leprosy Control Programme Manager Background Major public health problem Current (2014) notification rate is at 286/ 100,000 population. The

More information

SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m.

SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m. SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m. ISSUES NOTE Improving the Health Outcomes of Women and

More information

ADDRESSING MDR TB IN THE CONTEXT OF HIV: Lessons from Lesotho. Dr Hind Satti PIH Lesotho Director MDR-TB program

ADDRESSING MDR TB IN THE CONTEXT OF HIV: Lessons from Lesotho. Dr Hind Satti PIH Lesotho Director MDR-TB program ADDRESSING MDR TB IN THE CONTEXT OF HIV: Lessons from Lesotho Dr Hind Satti PIH Lesotho Director MDR-TB program TB Situation in Lesotho 12,275 TB new cases notified in 2007 Estimated prevalence of 544

More information

Nuestra Casa: Achievements and lessons learned in conducting an ACMS strategy

Nuestra Casa: Achievements and lessons learned in conducting an ACMS strategy Nuestra Casa: Achievements and lessons learned in conducting an ACMS strategy Dr. Eva Moya, Dr. Blanca Lomeli and Bruno Poncon Project Concern International SOLUCION TB Innovative ACMS to address TB and

More information

TUBERCULOSIS CONTACT INVESTIGATION

TUBERCULOSIS CONTACT INVESTIGATION TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE TUBERCULOSIS CONTACT INVESTIGATION LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1. Describe the criteria used

More information

Communicable Disease. Introduction

Communicable Disease. Introduction Communicable Disease HIGHLIGHTS Seniors have the highest incidence rates of tuberculosis compared to other age groups. The incidence rates for TB have been higher among Peel seniors compared to Ontario

More information

Impact of HIV infection on TB epidemic in Russia

Impact of HIV infection on TB epidemic in Russia Impact of HIV infection on TB epidemic in Russia Olga Nechaeva Head of the Federal Monitoring Center for Counteraction to Tuberculosis Spread in the Russian Federation, Federal Research Institute for Health

More information

Online Annexes (2-4)

Online Annexes (2-4) Online Annexes (2-4) to WHO Policy update: The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin THE END TB STRATEGY Online Annexes (2-4) to WHO Policy update:

More information

Audit of management of TB in HIV co-infected patients: survey of clinic arrangements

Audit of management of TB in HIV co-infected patients: survey of clinic arrangements Audit of management of TB in HIV co-infected patients: survey of clinic arrangements Please complete this questionnaire if your clinic/department provides TB treatment and care for adult patients, but

More information

Dr Clare van Halsema

Dr Clare van Halsema 19 th Annual Conference of the British HIV Association (BHIVA) Dr Clare van Halsema North Manchester General Hospital 16-19 April 2013, Manchester Central Convention Complex The effect of antiretroviral

More information

Time to implement: WHO guidelines on TB Preventive Treatment

Time to implement: WHO guidelines on TB Preventive Treatment Time to implement: WHO guidelines on TB Preventive Treatment WHO End TB Strategy TARGETS: 90% reduction of deaths and 80% reduction in incidence by 2030 Early diagnosis Integrated, of TB including universal

More information

TB/HIV prevention. Implementation science and TB prevention

TB/HIV prevention. Implementation science and TB prevention TB/HIV prevention Implementation science and TB prevention Success is moving from one failure to another with no loss of enthusiasm. ~ Sir Winston Churchill NSP and PFIP Impact indicators NSP Indicator

More information

Malaria Control in Togo

Malaria Control in Togo Malaria Control in Togo Introduction * Dr Kodjo Morgah In Collaboration with Dr Koubagnine Takpa (Director, EPI) Dr Jérome Agbekou (DPC/WHO/Togo) Dr Stephan Tohon (ICP/MAL/WA) Dr Jean Pierre E. Batchassi

More information

MEMORANDUM. Re: Guidance for follow-up of newly-arrived Individual with a Class B1 Tuberculosis Extrapulmonary Tuberculosis

MEMORANDUM. Re: Guidance for follow-up of newly-arrived Individual with a Class B1 Tuberculosis Extrapulmonary Tuberculosis MEMORANDUM To: From: Local Board of Health John Bernardo, MD, Tuberculosis Medical Officer Jennifer Cochran, MPH, Division Director Division of Global Populations and Infectious Disease Prevention Bureau

More information

Tuberculosis in Alameda County, 2009

Tuberculosis in Alameda County, 2009 Tuberculosis in Alameda County, 29 Alameda County Public Health Department Tuberculosis Overview Tuberculosis (TB) is a communicable disease caused by the bacteria Mycobacterium tuberculosis. TB is spread

More information

Implementing revised TB/HIV recording and reporting tools Country Experience. Dr Nathan Kapata National TB/ Leprosy Programme Manager

Implementing revised TB/HIV recording and reporting tools Country Experience. Dr Nathan Kapata National TB/ Leprosy Programme Manager Implementing revised TB/HIV recording and reporting tools Country Experience Dr Nathan Kapata National TB/ Leprosy Programme Manager Outline Objective Background Implementation of TB/HIV collaborative

More information

Tuberculosis & Refugees in Philadelphia

Tuberculosis & Refugees in Philadelphia Tuberculosis & Refugees in Philadelphia Philadelphia TB Control Program Daniel P. Dohony, MPH Philadelphia TB Control Program Health Information Portal Website: hip.phila.gov Contains Information On» Disease

More information

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases

More information

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 Definitions and reporting framework for tuberculosis 2013 revision Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 2-year revision process WHO/HTM/TB/2013.2 2 www.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf

More information